Heijman J - Search Results

1

Tools to Keep the Clock Ticking: Molecular Approaches to Treat Sinus Node Dysfunction.

Heijman J, Heusch G, Dobrev D. Heijman J, et al. Cardiology. 2015;132(1):45-8. doi: 10.1159/000430783. Epub 2015 Jun 4. Cardiology. 2015. PMID: 26044937 No abstract available.

2

I(Ks) restricts excessive beat-to-beat variability of repolarization during beta-adrenergic receptor stimulation.

Johnson DM, Heijman J, Pollard CE, Valentin JP, Crijns HJ, Abi-Gerges N, Volders PG. Johnson DM, et al. Among authors: heijman j. J Mol Cell Cardiol. 2010 Jan;48(1):122-30. doi: 10.1016/j.yjmcc.2009.08.033. Epub 2009 Sep 8. J Mol Cell Cardiol. 2010. PMID: 19744496

3

Local control of β-adrenergic stimulation: Effects on ventricular myocyte electrophysiology and Ca(2+)-transient.

Heijman J, Volders PG, Westra RL, Rudy Y. Heijman J, et al. J Mol Cell Cardiol. 2011 May;50(5):863-71. doi: 10.1016/j.yjmcc.2011.02.007. Epub 2011 Feb 21. J Mol Cell Cardiol. 2011. PMID: 21345340 Free PMC article.

4

Impaired Na⁺-dependent regulation of acetylcholine-activated inward-rectifier K⁺ current modulates action potential rate dependence in patients with chronic atrial fibrillation.

Voigt N, Heijman J, Trausch A, Mintert-Jancke E, Pott L, Ravens U, Dobrev D. Voigt N, et al. Among authors: heijman j. J Mol Cell Cardiol. 2013 Aug;61:142-52. doi: 10.1016/j.yjmcc.2013.03.011. Epub 2013 Mar 24. J Mol Cell Cardiol. 2013. PMID: 23531443 Free article.

5

Irregular rhythm and atrial metabolism are key for the evolution of proarrhythmic atrial remodeling in atrial fibrillation.

Heijman J, Dobrev D. Heijman J, et al. Basic Res Cardiol. 2015 Jul;110(4):41. doi: 10.1007/s00395-015-0498-1. Epub 2015 May 28. Basic Res Cardiol. 2015. PMID: 26018792 No abstract available.

6

New antiarrhythmic targets in atrial fibrillation.

Voigt N, Heijman J, Dobrev D. Voigt N, et al. Among authors: heijman j. Future Cardiol. 2015;11(6):645-54. doi: 10.2217/fca.15.67. Epub 2015 Nov 26. Future Cardiol. 2015. PMID: 26609872 Review.

7

The multiple proarrhythmic roles of cardiac calcium-handling abnormalities: triggered activity, conduction abnormalities, beat-to-beat variability, and adverse remodelling.

Heijman J, Schirmer I, Dobrev D. Heijman J, et al. Europace. 2016 Oct;18(10):1452-1454. doi: 10.1093/europace/euv417. Epub 2016 Jan 29. Europace. 2016. PMID: 26826138 No abstract available.

8

Challenges to the translation of basic science findings to atrial fibrillation therapies.

Heijman J, Dobrev D. Heijman J, et al. Future Cardiol. 2016 May;12(3):251-4. doi: 10.2217/fca-2016-0007. Epub 2016 Apr 19. Future Cardiol. 2016. PMID: 27091233 Free article. No abstract available.

9

Serine/Threonine Phosphatases in Atrial Fibrillation.

Heijman J, Ghezelbash S, Wehrens XH, Dobrev D. Heijman J, et al. J Mol Cell Cardiol. 2017 Feb;103:110-120. doi: 10.1016/j.yjmcc.2016.12.009. Epub 2017 Jan 7. J Mol Cell Cardiol. 2017. PMID: 28077320 Free PMC article. Review.

10

Targeting supraventricular ectopic complexes: Which approach should be used and how does it affect atrial fibrillation?

Heijman J, Dobrev D, Crijns HJGM. Heijman J, et al. Int J Cardiol. 2017 Oct 1;244:202-203. doi: 10.1016/j.ijcard.2017.06.013. Int J Cardiol. 2017. PMID: 28784443 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results